Farms.com Home   News

COVID-19 is Likely Leading more U.S. Farmers to File for Bankruptcy

COVID-19 is Likely Leading more U.S. Farmers to File for Bankruptcy

By Andy Uhler

Mitchell Hora is a seventh-generation family farmer in Washington County, Iowa. He plants corn and soybeans and said finances were tough even before this crisis. It costs more to grow the crops than he can charge for them.

“You run the numbers and it’s like, holy smokes, like how does this even get close to working?” Hora said.

He said most farmers in the United States can’t think about the future or invest in their farms because they’re living harvest to harvest.

“I gotta have maximum revenue coming in so I can pay off my debt, pay the next interest payment. And that is not good,” he said.

Long before the coronavirus pandemic hit, American farmers were struggling. They lost important export markets because of the U.S.-China trade war and growing international competition. Then this health crisis emerged and disrupted an already volatile supply chain. That has agricultural economists predicting a rise in farm bankruptcies across the United States.

Part of the problem is that 80% of farm assets are tied up in land values, and those values have been declining for the past few years. And now, COVID-19 has disrupted farmers’ supply chains.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.